These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 1706346)

  • 21. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Weiner DB; Liu J; Cohen JA; Williams WV; Greene MI
    Nature; 1989 May; 339(6221):230-1. PubMed ID: 2654648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
    Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
    Weiner DB; Kokai Y; Wada T; Cohen JA; Williams WV; Greene MI
    Oncogene; 1989 Oct; 4(10):1175-83. PubMed ID: 2571965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
    Wada T; Myers JN; Kokai Y; Brown VI; Hamuro J; LeVea CM; Greene MI
    Oncogene; 1990 Apr; 5(4):489-95. PubMed ID: 1970151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
    Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
    Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
    Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
    Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene.
    Brown-Shimer S; Johnson KA; Hill DE; Bruskin AM
    Cancer Res; 1992 Jan; 52(2):478-82. PubMed ID: 1345814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration.
    Cohen JA; Yachnis AT; Arai M; Davis JG; Scherer SS
    J Neurosci Res; 1992 Apr; 31(4):622-34. PubMed ID: 1374476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
    Sikes RA; Chung LW
    Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
    EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of epidermal growth factor on the expression of erb B2/neu oncogene in mouse embryo fibroblast cells].
    Zheng YS; Tong TJ
    Shi Yan Sheng Wu Xue Bao; 1992 Dec; 25(4):413-6. PubMed ID: 1363854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor.
    Chazin VR; Kaleko M; Miller AD; Slamon DJ
    Oncogene; 1992 Sep; 7(9):1859-66. PubMed ID: 1354348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
    Reardon DB; Hung MC
    J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.
    Wildenhain Y; Pawson T; Blackstein ME; Andrulis IL
    Oncogene; 1990 Jun; 5(6):879-83. PubMed ID: 1694290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
    Sistonen L; Hölttä E; Lehväslaiho H; Lehtola L; Alitalo K
    J Cell Biol; 1989 Nov; 109(5):1911-9. PubMed ID: 2572601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ; Robinson RA; Haddad SF; Moore SA
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.